This expert consensus protocol for carbapenem resistance detection and characterisation was jointly developed by the EURGenCCRE consortium, the scientific advisory board for EURGen-Net and ECDC to agree upon the protocol for phenotypic and genotypic carbapenem resistance detection and confirmation to be used for the CCRE survey.

This expert consensus protocol for colistin resistance detection and characterisation was jointly developed by the EURGen CCRE consortium, the scientific advisory board for EURGen-Net and ECDC to agree upon the best available strategy for phenotypic and genotypic colistin-resistance detection and confirmation to be used for the CCRE survey.

This ECDC study protocol describes the technical requirements for implementing future EU-level genomic-based surveillance of carbapenem-resistant and/or colistin-resistant Enterobacteriaceae.

This document explains the operating procedures of the European Legionnaires’ Disease Surveillance Network, coordinated by ECDC. It specifically relates to reporting cases of travel-associated Legionnaires’ disease arising from stays in hotel or other commercial holiday accommodation. The aim is to quickly identify and control outbreaks of the disease and minimise the risk to holidaymakers. This edition supersedes the January 2012 edition.

This protocol is to ensure standardisation of definitions, data collection and reporting procedures for hospitals participating in the national/regional surveillance of surgical site infections across Europe.

This protocol is to ensure standardisation of definitions, data collection and reporting procedures for hospitals participating in the national/regional surveillance of healthcare-associated infections in intensive care units across Europe.

This updated protocol prescribes the methodology, and provides the data collection tools required to achieve the objectives of European surveillance of CDIs.

Version 5.3 is the final protocol for the second EU-wide point prevalence survey (PPS 2016–2017). It contains major changes compared to protocol version 4.3 (PPS 2011–2012). Compared to versions 5.1 (January 2016) and 5.2 (May 2016), the current version only contains a few corrections, editorial changes and clarifications.

The Protocol is targeted at the national public health reference laboratories to guide the susceptibility testing needed for EU surveillance and the reporting to ECDC.

This protocol provides national survey coordinators (NSCs) and national/regional validation teams (VTs) with the methodology, data collection forms and definitions of variables to collect data during the HALT-3 project.